PeerView Clinical Pharmacology CME/CNE/CPE Video
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇬🇷GR · Science#105500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
150 to 900🎙 Daily cadence·932 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇬🇷100% - Active Followers
Loyal subscribers who consistently listen
150 to 900
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 30 epsHosts
Not detected.
Recent guests
Recent episodes
Shubham Pant, MD - Restructuring Clinical Care Models in Pancreatic Cancer: Expert Guidance on Improving Patient Outcomes With Modern Therapeutic Strategies in Community Settings
Jul 20, 2026
1h 01m 26s
Chafic Karam, MD / Michelle Kittleson, MD, PhD - All-in for Transthyretin Amyloidosis: Refining Team-Based Approaches to Diagnosis, Treatment, and Lifesaving Patient-Centered Care
Jul 20, 2026
54m 36s
Jill Stratford Waldron, APRN, GNP-BC - Winning Strategies for Managing Transthyretin Cardiac Amyloidosis: The Heart Failure Nurse’s Game Plan
Jul 20, 2026
1h 04m 47s
Jennifer Chan, MD, MPH - Personalized Interventions in Neuroendocrine Tumors: Applying the Latest Systemic Therapy Evidence to Guide Treatment Decisions in Community-Based Settings
Jul 20, 2026
1h 03m 19s
Yelena Y. Janjigian, MD* - Scaling New Heights in Gastric/GEJ Cancer: Aligning the Evidence on Targeted and Immunotherapeutic Approaches Across the Disease Continuum
Jul 20, 2026
1h 31m 14s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | Pancreatic CancerClinical Care Models+4 | Shubham Pant, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | pancreatic cancerclinical care+4 | Revolution Medicines | 1h 01m 26s | ||
| 7/20/26 | Transthyretin AmyloidosisTeam-Based Approaches+3 | Chafic Karam, MDMichelle Kittleson, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Transthyretin Amyloidosisdiagnosis+3 | Alnylam Pharmaceuticals, Inc. | 54m 36s | ||
| 7/20/26 | Transthyretin Cardiac AmyloidosisHeart Failure+3 | Jill Stratford Waldron | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Transthyretin Cardiac Amyloidosisheart failure+3 | Alnylam Pharmaceuticals, Inc. | 1h 04m 47s | ||
| 7/20/26 | neuroendocrine tumorspersonalized interventions+4 | Jennifer Chan, MD, MPH | PVI, PeerView Institute for Medical EducationNeuroendocrine Cancer Awareness Network | — | neuroendocrine tumorspersonalized medicine+5 | Exelixis, Inc. | 1h 03m 19s | ||
| 7/20/26 | Gastric CancerGEJ Cancer+4 | Yelena Y. Janjigian, MD | PVI, PeerView Institute for Medical EducationHope For Stomach Cancer+3 | — | gastric cancerGEJ cancer+5 | AstraZeneca | 1h 31m 14s | ||
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/13/26 | ASCVDlipid management+3 | Christie M. Ballantyne, MD, MNLA, FACP, FACCJessica M. Peña, MD, MPH, FACC, FNLA, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | ASCVDlipid management+3 | Merck & Co., Inc. | 57m 21s | ||
| 7/13/26 | lung cancerbreast cancer+4 | Prof. David Planchard, MD, PhDPaolo Tarantino, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | lung cancerbreast cancer+5 | AstraZeneca | 36m 10s | ||
| 7/13/26 | HIV ManagementTherapeutic Advances+3 | Paul E. Sax, MDEileen Scully, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | HIVTherapeutics+5 | Merck & Co., Inc. | 1h 03m 22s | ||
| 7/13/26 | ImmunotherapyMelanoma+3 | Hussein Tawbi, MD, PhD | PVI, PeerView Institute for Medical Education | Rahway, NJ, USA | immunotherapymelanoma+4 | Bristol Myers Squibb | 1h 33m 29s | ||
| 6/5/26 | Hepcidin PathwayPatient Outcomes+3 | Andrew Kuykendall, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Polycythemia VeraHepcidin+5 | Takeda Pharmaceuticals U.S.A., Inc. | 31m 51s | ||
| 6/4/26 | immunotherapyNSCLC+4 | Brendon M. Stiles, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | Rahway, NJ, USA | immunotherapyNSCLC+5 | AstraZeneca | 1h 05m 50s | ||
| 5/29/26 | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Jaume Capdevila, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 54m 53s | ||
| 5/29/26 | Oncology NursingImmunotherapy+3 | Charise GleasonBeth Faiman | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | RRMMOncology+4 | GSK | 59m 51s | ||
| 5/29/26 | InflammationFibrosis+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | inflammationfibrosis+4 | Merck & Co., Inc. | 1h 10m 58s | ||
| 5/29/26 | NF1-PNMEK Inhibition+3 | Amy E. Armstrong, MDAngela Hirbe, MD, PhD | PVI, PeerView Institute for Medical EducationNeurofibromatosis Network | — | NF1-PNMEK Inhibition+4 | Alexion | 1h 05m 17s | ||
| 5/29/26 | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | ||
| 5/29/26 | cognitive declinedementia risk+4 | Anna Chodos, MD, MPH | PVI, PeerView Institute for Medical EducationBrightFocus Foundation+3 | — | cognitive declinedementia+6 | Lilly | 46m 16s | ||
| 5/29/26 | Asparaginase ExposurePersonalized Treatment+3 | Luke Maese, DORachel Rau, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | AsparaginasePediatric Patients+6 | Jazz Pharmaceuticals | 48m 37s | ||
| 5/29/26 | advanced ovarian cancerpersonalized treatment plans+3 | Bhavana Pothuri, MD, MSPremal Thaker, MD, MS | PVI, PeerView Institute for Medical EducationNational Ovarian Cancer Coalition+3 | — | ovarian cancertargeted therapy+3 | GSK | 51m 15s | ||
| 5/7/26 | RSVvaccine access+3 | Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPHRichard Dang, PharmD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | RSVvaccine+5 | GSK | 59m 54s | ||
| 5/7/26 | Psoriasis careOral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | psoriasisIL-23 inhibitors+3 | Johnson & Johnson | 33m 41s | ||
| 5/7/26 | Alzheimer's DiseaseAPOE Status+4 | Professor Christopher ChenProfessor Atsushi Iwata, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | APOEAlzheimer's Disease+4 | Lilly | 45m 04s | ||
| 5/7/26 | PCSK9 InhibitionLDL-C Targets+3 | Christie M. Ballantyne, MD, FACP, FACC | PVI, PeerView Institute for Medical EducationThe Mended Hearts, Inc. | Rahway, NJ, USA | PCSK9LDL-C+5 | Merck & Co., Inc. | 1h 22m 52s | ||
| 5/7/26 | Restless Legs SyndromeTreatment Guidelines+3 | J. Andrew Berkowski, MD, FAASM | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Restless Legs Syndrometreatment gaps+5 | Noctrix Health, Inc. | 46m 37s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for PeerView Clinical Pharmacology CME/CNE/CPE Video
Peaked at #105 in GR, currently #105 in GR.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| GR | — | #105 | #105 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.